Sekar Kathiresan - Net Worth and Insider Trading
Sekar Kathiresan Net Worth
The estimated net worth of Sekar Kathiresan is at least $4 Million dollars as of 2024-11-13. Sekar Kathiresan is the CEO of Verve Therapeutics Inc and owns about 639,833 shares of Verve Therapeutics Inc (VERV) stock worth over $4 Million. Details can be seen in Sekar Kathiresan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sekar Kathiresan has not made any transactions after 2022-10-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sekar Kathiresan
Sekar Kathiresan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sekar Kathiresan owns 2 companies in total, including Verve Therapeutics Inc (VERV) , and Relay Therapeutics Inc (RLAY) .
Click here to see the complete history of Sekar Kathiresan’s form 4 insider trades.
Insider Ownership Summary of Sekar Kathiresan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VERV | Verve Therapeutics Inc | 2022-10-03 | director & 10 percent owner & Chief Executive Officer |
| RLAY | Relay Therapeutics Inc | 2022-07-25 | director |
Sekar Kathiresan Latest Holdings Summary
Sekar Kathiresan currently owns a total of 1 stock. Sekar Kathiresan owns 639,833 shares of Verve Therapeutics Inc (VERV) as of October 3, 2022, with a value of $4 Million.
Latest Holdings of Sekar Kathiresan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VERV | Verve Therapeutics Inc | 2022-10-03 | 639,833 | 6.43 | 4,114,126 |
Holding Weightings of Sekar Kathiresan
Sekar Kathiresan Form 4 Trading Tracker
According to the SEC Form 4 filings, Sekar Kathiresan has made a total of 6 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Verve Therapeutics Inc is the sale of 50,000 shares on October 3, 2022, which brought Sekar Kathiresan around $2 Million.
Insider Trading History of Sekar Kathiresan
- 1
Sekar Kathiresan Trading Performance
Sekar Kathiresan Ownership Network
Ownership Network List of Sekar Kathiresan
Ownership Network Relation of Sekar Kathiresan
Sekar Kathiresan Owned Company Details
What does Verve Therapeutics Inc do?
Who are the key executives at Verve Therapeutics Inc?
Sekar Kathiresan is the director & 10 percent owner & Chief Executive Officer of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include See Remarks Andrew D. Ashe , Chief Administrative Officer Joan Nickerson , and director & 10 percent owner Krishna Yeshwant .
Verve Therapeutics Inc (VERV) Insider Trades Summary
Over the past 18 months, Sekar Kathiresan made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 1,800,000 shares made by Krishna Yeshwant , a net purchase of 76,000 shares made by Andrew D. Ashe , and a net sale of 1,514 shares made by Joan Nickerson .
In summary, during the past 3 months, insiders sold 0 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,068 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,932 shares.
Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verve Therapeutics Inc Insider Transactions
Sekar Kathiresan Mailing Address
Above is the net worth, insider trading, and ownership report for Sekar Kathiresan. You might contact Sekar Kathiresan via mailing address: 500 Technology Square, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
